Variables with category
|
Frequency
|
Percentage (%)
|
---|
Age
|
15–24
|
175
|
42.89
|
25–34
|
123
|
30.15
|
35–44
|
49
|
12.01
|
45–54
|
24
|
5.88
|
55–64
|
25
|
6.13
|
65–80
|
12
|
2.94
|
Sex
|
Male
|
243
|
59.56
|
Female
|
165
|
40.44
|
Residence
|
Urban
|
247
|
60.54
|
Rural
|
161
|
39.46
|
Marital status
|
Single
|
233
|
57.11
|
Married
|
138
|
33.82
|
Divorced
|
26
|
6.37
|
Widowed
|
11
|
2.7
|
Educational level
|
No formal education
|
158
|
38.72
|
Primary
|
118
|
28.91
|
Secondary
|
79
|
19.36
|
Higher
|
53
|
13
|
Occupation
|
Student
|
133
|
32.6
|
Farmer
|
111
|
27.21
|
Merchant
|
33
|
8.09
|
Employee
|
45
|
11.03
|
Housewife
|
50
|
12.25
|
Other
|
36
|
8.82
|
Wealth index
|
Poor
|
153
|
37.5
|
Middle
|
146
|
35.78
|
Rich
|
109
|
26.72
|
Type of drug when treatment started
|
Phenobarbital
|
255
|
62.5
|
Phenytoin
|
55
|
13.48
|
Carbamazepine
|
15
|
3.68
|
Two or more drugs
|
79
|
19.36
|
Othera
|
4
|
0.98
|
Adherence
|
Low
|
100
|
24.57
|
Moderate
|
127
|
31.2
|
High
|
180
|
44.23
|
Duration of treatment (years)
|
< 1
|
52
|
12.75
|
1–5
|
204
|
50
|
5–10
|
98
|
24.02
|
> 10
|
54
|
13.23
|
Treatment modality
|
Mono
|
308
|
75.49
|
Poly
|
100
|
24.51
|
Current medication
|
Phenobarbital
|
253
|
62.01
|
Phenytoin
|
31
|
7.6
|
Carbamazepine
|
13
|
3.19
|
Two or more drugs
|
106
|
25.98
|
Othera
|
5
|
1.22
|
Tapering in the last 2 months
|
Yes
|
21
|
5.15
|
No
|
387
|
94.85
|
Treatment side effect
|
Yes
|
38
|
9.31
|
No
|
370
|
90.69
|
Treatment affordability
|
Yes
|
259
|
63.48
|
No
|
149
|
36.52
|
- aOther: lamotrigine, sodium valproate and haloperidol